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Abstract
Background: Chronic hepatitis B virus infection (HBV) is an important health problem in the Turkish community in
the Netherlands, and promotion of screening for HBV in this risk group is necessary. An individually tailored
intervention and a culturally tailored intervention have been developed to promote screening in first generation
16-40 year old Turkish immigrants. This paper describes the design of the randomized controlled trial, which will
be used to evaluate the effectiveness of the two tailored internet interventions as compared to generic online
information on HBV, and to assess the added value of tailoring on socio-cultural factors.
Methods/Design: A cluster randomized controlled trial design, in which we invite all Rotterdam registered
inhabitants born in Turkey, aged 16-40 (n = 10,000), to visit the intervention website is used. A cluster includes all
persons living at one house address. The clusters are randomly assigned to either group A, B or C. On the website,
persons eligible for testing will be selected through a series of exclusion questions and will then continue in the
randomly assigned intervention group. Group A will receive generic information on HBV. Group B will receive
individually tailored information related to social-cognitive determinants of screening. Group C will receive
culturally tailored information which, next to social-cognitive factors, addresses cultural factors related to screening.
Subsequently, participants may obtain a laboratory form, with which they can be tested free of charge at local
health centres. The main outcome of the study is the percentage of eligible persons tested for HBV through to
participation in one of the three groups. Measurements of the outcome behaviour and its determinants will be at
baseline and five weeks post-intervention.
Discussion: This trial will provide information on the effectiveness of a culturally tailored internet intervention
promoting HBV-screening in first generation Turkish immigrants in the Netherlands, aged 16-40. The results will
contribute to the evidence base for culturally tailored (internet) interventions in ethnic minority populations. An
effective intervention will lead to a reduction of the morbidity and mortality due to HBV in this population. This
may not only benefit patients, but also help reduce health inequalities in western countries.
Trial Registration: The Netherlands National Trial Register NTR 2394.
Background
Hepatitis B virus infection (HBV) is one of the major
infectious diseases in the world [1]. Each year, around
1,800 HBV infections, 79% of which are chronic, are
reported in the Netherlands [2]. Chronic HBV infections
cause 23% of all liver cancers in the Netherlands, and
are an important problem in the Turkish community,
which is the Netherlands’ largest group of immigrants
from non-industrialized countries [3,4]. While this com-
munity represents 8% of the total city population in Rot-
terdam (with 45,415 people), it accounts for 30% of
reported chronic HBV infections [5]. Seventy percent of
reported infections among Turks involve people aged
between 16 and 40 years. In this age-category, the mean
incidence of reported HBV infections is 122 per 100,000
individuals of Turkish origin, much higher than the 35
infections per 100,000 persons reported in the total
population of Rotterdam [6]. However, these figures
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underestimate the population prevalence: many chronic
HBV patients do not have the signs and symptoms of
disease, and are therefore not reported. Population-
based studies indicate a prevalence of chronic HBV of
0.2% in the general Dutch population, and a much
higher prevalence of 2.6 - 4.8% in first generation Turk-
ish immigrants (i.e. those born in Turkey) [4,7-9]. These
studies furthermore show that the prevalence of chronic
HBV in second generation Turks is similar to the gen-
eral Dutch population.
The majority of Turkish patients with chronic infec-
tion have acquired HBV through infection from mother
to child at birth, or through infection at a young age by
blood contact with household members [10,11]. Carriers
of the virus may infect others by blood contact or, later
in life, through sexual contact [12].
In Turkey, every newborn is vaccinated in the first 24
hours since 1998 [13]. Furthermore, adolescent catch-up
vaccinations ensured that adolescents up to the age of
16 years had been vaccinated by 2008[14]. Current
national HBV-control policies in the Netherlands focus
on screening pregnant women and on vaccinating speci-
fic risk groups, such as newborns from HBV-infected
mothers (since 1989), children with at least one parent
from an HBV-endemic area (since 2003), and people
with high-risk behaviour (since 2002) [12]. These pro-
grammes leave a substantial part of the adult Turkish
population in the Netherlands undetected and unpro-
tected regarding HBV. Furthermore, in the past decade,
treatment options of chronic HBV have improved [15].
In order to detect individuals eligible for treatment and
to prevent transmission, screening for HBV should be
promoted through public health interventions targeted
specifically in first generation Turkish immigrants.
Tailoring interventions to determinants of health
behaviour has proven to be effective in health promo-
tion [16], also related to infectious diseases [17,18], and
in promotion of screening participation [19,20]. Relevant
social-cognitive determinants for this specific target
population, derived from common health behaviour the-
ories, focus group discussions, and a survey question-
naire in the Turkish population in the Netherlands
[21,22] (YJJ van der Veen et al.: Social-cognitive and
socio-cultural predictors of hepatitis B screening beha-
viour in Turkish Dutch, submitted), were the low aware-
ness and knowledge regarding hepatitis B and its
prevention, and the attitude, self-efficacy, social support
and subjective norm regarding hepatitis B-screening in
the target population. Up to now, tailored interventions
are most often based on such individual factors, also
called the proximal determinants of health behaviour.
However, these proximal determinants may be depen-
dent on more distal social-cultural factors [23]. These
factors ask for ‘cultural tailoring’ of interventions
including cultural traditions, values, and norms in tai-
lored strategies [24,25]. In our previous work regarding
the determinants of HBV-screening behaviour, we also
identified socio-cultural factors related to HBV-screen-
ing. These were shame and stigma regarding HBV, the
association of HBV-screening with sexuality, the impor-
tance of family values, religious values and rules regard-
ing health, and the level of satisfaction with the Dutch
health care.
A relatively easy way of tailoring health information
for specific groups is using information and communica-
tion technology (ICT) and the Internet. Advantages for
health promotion include the interactivity, use of active
learning methods, multimedia presentation, temporal
flexibility, and low costs relative to its potential popula-
tion reach [26]. An important condition for success of
tailored internet interventions is basic access to the
internet. Research in the Netherlands has shown an
increase in access to computers and the Internet in the
population in general, and in the Turkish community as
well [27]. In our survey, we found that 87% of the Turks
had a computer at home, and that an equal part of the
population used the internet. The majority (90%) of
men and the younger women (16-28 years) who used
the internet did this daily or at least a few times per
week. Seventy-five percent of the women above the age
of 28 years said to use the internet frequently. Of the
20% of women in this age group who said not to use
internet themselves, about 70% reported to live with
someone in the house who did make use of the internet.
The effect of tailoring in behaviour-focussed infectious
disease control and the added value of including cultural
tailored approaches has not been studied to date. We
therefore recently developed two internet interventions
aiming to promote screening in first generation Turkish
immigrants aged 16 to 40 years, using the Intervention
Mapping approach (YJJ van der Veen et al.: Develop-
ment of a culturally tailored internet intervention pro-
moting hepatitis B screening in the Turkish Dutch
community, submitted). Intervention Mapping (IM)
describes the stepwise process for the development of
theory- and evidence based and practice-based interven-
tions [28].
Tailoring is defined as any combination of information
or change strategies intended to reach one specific per-
son, based on characteristics that are unique to that per-
son, related to the outcome of interest, and have been
derived from an individual assessment [29]. The indivi-
dually tailored intervention focuses on social-cognitive
determinants of screening behaviour, such as awareness,
knowledge, attitude, self-efficacy, perceived subjective
norm and support, susceptibility to HBV, and personal
norms related to health. Cultural tailoring may be
defined as tailoring a health message ‘which recognizes
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and reinforces a group’s cultural values, beliefs, and
behaviours and built upon those to provide context and
meaning to the message about a given health problem
or behaviour’ [25]. Cultural tailoring is expected to have
even more impact on behaviour than tailoring, by paying
attention to the embeddedness of human health beha-
viour in the cultural context and social structure [30].
Cultural sensitivity in tailoring can be conceptualized in
terms of two primary dimensions: surface structure and
deep structure [25]. We used surface structure elements
in order to increase the comprehension and acceptance
of messages, by matching intervention materials and
messages to characteristics of the target population,
such as the language and role models preferred by the
target audience. We used deep structure elements to
convey salience, by understanding how members of the
priority population perceive the cause, course, and treat-
ment of hepatitis B, as well as how they perceive the
determinants of the desired screening behaviour. We
addressed factors such as religion and family values that
influence screening behaviour. A detailed description of
the intervention is described elsewhere (YJJ van der
Veen: Development of a culturally tailored internet
intervention promoting hepatitis B screening in the
Turkish Dutch community, submitted).
This study aims to evaluate the effectiveness of the
two tailored internet interventions as compared to gen-
eric online information on HBV, and to assess the




We apply a cluster randomised controlled trial to study
the effect of the individually tailored internet interven-
tion (group B) and the culturally tailored internet inter-
vention (group C) on screening behaviour, compared to
generic online information (group A). Measurements of
screening behaviour (i.e. being screened for HBV (yes/
no)) and of the determinants of this behaviour will be at
baseline and one month post-intervention.
Study population
The study population consists of 16-40 year-old citizens
of Rotterdam, born in Turkey. Excluded from the study
are those:
- not registered in the municipal population registers
(MPR)
- aware of having been tested, and knowing to be a
carrier of HBV
- aware of having been tested, and being immune
- aware of having been fully vaccinated
Recruitment of the study population
From the municipal public registration (MPR) we will
retrieve names and address details of all persons aged
16-40 years (as per 1 September 2010) who are first
generation Turkish immigrants. All subjects will be pro-
vided with a unique client ID, which we have randomly
assigned to one of the three intervention groups.
Respondents will be recruited to visit the website by
means of a personal invitation by postal mail. The invi-
tations will be sent out from 13 September to 17
December, 2010. This period was chosen because of the
end of the Ramadan on 9 September, 2010. The plan-
ning will ensure that all persons living at the same
house address will receive the invitation on the same
day. Simultaneously, an information campaign in the
Turkish community in Rotterdam will be conducted,
using newspapers, local radio, community-based organi-
sations and key figures in the Turkish community. Addi-
tionally, respondents will be recruited through links on
websites with general health information and websites
directed specifically at the Turkish community.
In the personal invitation, the addressees will be
referred to the internet. On the homepage of the project
a short explanation of the health problem of HBV is
given, together with information about the facilities pro-
vided at the website. Visitors of the website are only
able to log in on the website by using their client ID
provided in the personal invitation. The website will be
offered bilingually, i.e. the visitor may choose between
the Dutch or Turkish language. Visitors will then be
guided through some exclusion questions in order to
select persons eligible for testing (see exclusion criteria).
Randomisation and exposure to the intervention
All persons living at the same address (i.e. family members
or house-mates), will be assigned randomly to one of the
three research groups: standard information (group A),
individually tailored information (group B) and culturally
tailored information (group C). Participants in the control
(group A) and intervention groups (groups B and C) are
thus enrolled in the same way. Those who enter the inter-
net page and show to be eligible for testing will be ques-
tioned for demographic information and asked for a
current email address for participation in a follow-up
questionnaire. When participants stop during the internet
session, and log in using their client ID later on, they will
continue in the same group.
During the intervention, participants provide informa-
tion on both social-cognitive and socio-cultural determi-
nants by answering questions on their beliefs and
expectations regarding hepatitis B screening. This infor-
mation and the provided demographic data will be
linked to the client ID and saved in a database. At the
van der Veen et al. BMC Public Health 2010, 10:674
http://www.biomedcentral.com/1471-2458/10/674
Page 3 of 8
end of the information session or tailored intervention,
participants may choose to receive a laboratory form
either by email or post. Prior to receiving the form, they
will receive client information, in which the procedure
of testing, possible results of the test and follow-up is
explained. Participants will then be asked to sign a
checkbox for informed consent. Participants are also
asked to co-operate in a follow-up questionnaire about
the website one month after the date of first website
visit. The laboratory form will be either sent by email or
mail, and the client information is once more included.
When the participant is younger than 18 years at the
date of printing the form, a signed consent from the
parents is needed on the form. In that case, information
for the parents will be included in the client informa-
tion. For individuals unable to use the internet, we will
provide the laboratory form with generic information on
HBV on request by postal mail. However, these indivi-
duals are excluded from the research population, as they
are not exposed to one of the three interventions.
Test site (location for blood sampling)
Test sites (n = 85) are community health centres conve-
niently located in the neighbourhoods where partici-
pants live. The blood samples will be analysed according
to a predefined standard test algorithm (see Figure 1).
The laboratory will inform the Municipal Public Health
Service (MPHS) about the test result by providing client
ID, date of birth, postal code and test results.
Follow-up actions
All HBc-negative results (indicating that persons have
not been in contact with the virus) can be sifted out by
non-medical staff of the MPHS. All HBc-postive results
will be assessed by a medical doctor. Accordingly, all
test results will be entered into the client registration
system of the MPHS based on name of the person
(which may be retrieved using the client ID). This client
registration system will automatically distribute a stan-
dard letter with the results to the participant. The four
possible outcomes of the test are: (1) being susceptible
to HBV; (2) being immune for HBV due to previous
infection; (3) being a HBV carrier, already registered
with the MPHS; (4) being a carrier, not registered with
the MPHS yet (see Figure 1).Susceptible persons will be
informed about their test result, and will be advised to
be vaccinated (at a reduced rate) at the MPHS. Immune
persons are informed about their test result and the fact
that no further action is required. MPHS registered car-
riers will be informed about their result, and that no
further action is required as they have received adequate
care in the past. Non-registered carriers will be
informed about their status, and will be requested to
visit the MPHS for a counselling session and a second
blood sample for determination of the liver function
through an ALT test. Elevated ALT levels indicate liver
inflammation, and these participants will be referred to
a medical specialist. In case of normal ALT levels, the
participants are referred to their GP for a yearly check-
Figure 1 Standard test algorithm for Hepatitis B screening in Turkish Dutch.
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up. In all letters, a telephone number for additional
questions is provided. Figure 2 represents the project’s
flow-chart, indicating the flow from the moment the
participant logs in on the project website, through a
visit to the community health centre for blood sampling,
and the remaining procedure at the MPHS once the test
result is known.
Follow-up measurements
If test results have not been received by the MPHS four
weeks after the laboratory form request, participants who
have indicated to wish to be reminded of the testing, are
sent a reminder email. Five weeks after the first log-in,
participants who provided an email-address and have
given consent for being approached for further research,
will receive an email with a link to the website where a
short questionnaire on social-cognitive and socio-cultural
determinants, and the perceived quality of the interven-
tion is presented. After completion of the questionnaire,
participants may indicate whether they want to join in a
raffle (based on email-addresses) of gift vouchers, as a
token of appreciation for their participation.
Sample size
The size of the total first generation Turkish population
in Rotterdam aged 16-40 years is approximately 10,000.
We expect that after having received the letter, approxi-
mately 60% of this population will go to the website
(n = 6000, i.e. 2000 visitors in each group), and that half
of that group will receive a test-advice and laboratory
form (n = 3000, 1000 in each arm of the study). We
hypothesize that in the three groups (standard informa-
tion, individually tailored information and cultural tai-
lored information) 20%, 35% and 45%, respectively, will
go to the test location and be tested for HBV (n = 200,
n = 350, n = 450, respectively). Accordingly, power cal-
culations for the difference in compliance with the
advice between the tailored and cultural tailored group,
show a power of more than 0.90. Because of clustering
in families (we randomize by house address), we take
Figure 2 Flowchart Hepatitis B screening in Turkish Dutch.
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into account the effect of the cluster ‘family’, which may
affect the power. Therefore we take a power of 0.90 as
acceptable instead of the standard 0.80. Our hypothesis
would lead to a total of 1000 tested persons, approxi-
mately 10% of the total target population. Based on
responses in other studies, we expect that this predicts
the actual response reasonably well [31-34].
Measures
During the intervention, we will gather the following
information:
Demographic factors: gender, age, socio-economic sta-
tus (SES) of the residential area (categorized in low-
mid/high SES by postal code), marital status, level of
education (low-medium-high), income situation, type of
health insurance, religion, and whether the person
knows someone with HBV.
Social-cognitive factors: awareness, knowledge, atti-
tude, self-efficacy, perceived subjective norm and sup-
port, susceptibility to HBV, personal norms related to
health and the screening intention.
Socio-cultural factors: satisfaction with the Dutch
health care and perceived rules regarding health and
disease.
Primary outcome measure
The primary outcome variable is having been tested due
to the intervention (yes/no). The data will be available
from the client registration system from the MPHS.
Secondary outcome measures
The follow-up questionnaire will provide information on
secondary outcomes by measuring the change in the fol-
lowing determinants one month after logging in on the
website:
Awareness: In the past three months, did you think
about a hepatitis B test? Answering options: never heard
of a HBV-test, never thought of a HBV-test, heard of a
HBV-test but not decided, heard of a HBV-test and
decided (not) to take it, have had a HBV-test. The mea-
sure was based on the Precaution Adoption Process
Model (PAPM) [35] and adapted from Costanza [36].
The awareness score may range from 0 to 5.
Knowledge is measured by five statements in order to
provide tailored information about the most important
issues of HBV for this population. The items were on
the contagiousness of HBV, the main route of transmis-
sion in Turks, the occurrence in Turks, the serious con-
sequences of HBV and the prevention of HBV. The
knowledge score may range from 0-5.
Attitude is measured by six items about three pro’s
(each may score 1 point) and three con’s (each may
score -1) of HBV testing. The attitude score may range
from -3 to 3.
Self-efficacy is measured by 4 items (on a scale from
1-10) about the ability to discuss testing with parents
and/or partner, the ability to communicate with a doc-
tor about the test, and to arrange testing.
Subjective norm is measured by asking whether the
participant thinks parents and/or partner feels testing is
important (scale 1-10).
Social support is measured by multiplying the scores
on two questions: 1.) whether the participant thinks par-
ents and/or partner will support the participant in test-
ing (yes (1)/no (-1)), and 2.) whether this is important
for the participant (yes (1)/no (0)). The score may range
from -1 (negative support) to 1 (positive support).
Susceptibility to HBV is measured by asking the parti-
cipant to indicate how susceptible he/she feels regarding
HBV, and to ask how he rates his susceptibility related
to other inhabitants of the Netherlands. Both items are
measured on a 10 point scale (very low chance, very
high chance).
Personal norm is measured by two items ‘I should
care well for my own health’ and ‘I am responsible for
the health of others’ on a five point scale (agree (1) -
disagree (5)).
Perceived rules is measured by asking persons who
indicated to be religious whether they perceive rules in
their religious community about: how to deal with
health, how to prevent disease, being responsible for
one’s own health/the health of others. Answers may be
yes (1) or no (0), which may result in a rules-score of
0-4.
Satisfaction with Dutch health care is measured on a
five-point scale by three statements on the cost of health
care, the experience of doctors, and satisfaction with the
Dutch health care in general.
Screening intention is measured on a five-point scale
by asking whether the participant intends to be tested
within three months (for sure (5) - surely not (1)).
Analysis
Because the primary outcome variable is the percentage
of eligible persons having been tested due to the inter-
vention (yes/no), we will perform univariate and multi-
variate logistic regression analysis. Independent variables
that will be included in the regression analysis are the
demographic, social-cognitive and socio-cultural factors.
Process evaluation
The follow-up questionnaire addresses issues of quality
by questioning: the comprehensibility, the reliability, the
relevance, and the applicability of the content [37]. We
will be able to assess the perceived reach by the number
of returned invitations; and the perceived dose by the
number of visitors and the number of components
viewed (obtained from the website statistics).
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Discussion
This trial will determine the effectiveness of a cultural
tailored internet intervention promoting HBV-screening
in first generation Turkish immigrants, aged 16-40
years, living in Rotterdam.
It is difficult to estimate the expected response rate
because this study is the first in this population using a
culturally tailored internet approach. In order to gener-
ate sufficient power to show the value of the individually
tailored and the culturally tailored intervention, we will
need at least 1000 participants, 10% of the total target
population. Regular public health interventions such as
PAP smear testing for cervical cancer, show response
rates in the range of 49.8% to 67.7% in Turkish immi-
grants in the Netherlands, with invitations from general
practitioners having a higher response compared to invi-
tations from the MPHS [38]. In a community project in
which individuals were invited to be tested for hepatitis
B (by mail for a personal consultation at the community
centre), the response among the Turkish population was
26% [31]. A recently introduced Chlamydia screening
programme in 16-29 year-old inhabitants of three area’s
in the Netherlands also used a combination of a perso-
nal invitation by post and the option to request a test
package through the internet. This resulted in a
response of 16% in the general population [33]. An
important factor in motivating the invited people to par-
ticipate might be the endorsement of our project by
community leaders. We therefore have asked for the
advice of community leaders in the development phase
of the project. We also plan to specifically address com-
munity leaders and community-based organisations dur-
ing the information campaign in the Turkish
community in Rotterdam, using community-based orga-
nisations and key figures in the Turkish community.
However, it remains to be seen whether the members of
the target community that are involved, sufficiently
represent their community in order to facilitate imple-
mentation of the intervention. Furthermore, next to the
primary outcome (having been tested or not) it is
important to learn from possible changes in social-cog-
nitive and socio-cultural determinants related to HBV-
screening. It has recently been shown that follow-up
questionnaires have high drop-out rates [39]. The raffle
of gift vouchers may help motivate people to fill out the
questionnaire.
In the past decade, health promotion interventions
have increasingly used the internet for the delivery of
health messages tailored to the needs of the individual,
and these have proven to be effective in changing
behaviour [40,41], but the need for addressing cultural
factors in tailored programmes has been emphasized
[16]. Although it is widely accepted that disease preven-
tion efforts should consider cultural factors when
addressing the needs of diverse populations, there is lit-
tle evidence that doing so enhances effectiveness [42].
To our knowledge, randomised controlled trials have
only been used to measure the effect of cultural tailored
messages on cancer prevention behaviour [24]. The
results of this study will contribute to the general evi-
dence base for culturally tailored (internet) interventions
in ethnic minority populations.
This study also responds to a recent call for migrant
screening on viral hepatitis [43]. Currently, chronic
HBV infections in migrants are less likely to be detected
than those in other high-risk populations, such as men
who have sex with men or injecting drug users, who in
the Netherlands are targeted for screening and vaccina-
tion. Therefore, migrant screening may not only benefit
patients and reduce the burden of illness and costs for
the health care system of long-term complications due
to chronic HBV infection, but also help to reduce health
inequalities in western countries.
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